Display options
Cite
Sabzghabaee AM, Abedi D, Fazeli H, et al. Antimicrobial resistance pattern of bacterial isolates from burn wounds in an Iranian University Hospital. J Res Pharm Pract. 2012;1(1):30-3doi: 10.4103/2279-042X.99675.
Sabzghabaee, A. M., Abedi, D., Fazeli, H., Javadi, A., Jalali, M., Maracy, M. R., Soltani, R., & Karamyafti, M. J. (2012). Antimicrobial resistance pattern of bacterial isolates from burn wounds in an Iranian University Hospital. Journal of research in pharmacy practice, 1(1), 30-3. https://doi.org/10.4103/2279-042X.99675
Sabzghabaee, Ali Mohammad, et al. "Antimicrobial resistance pattern of bacterial isolates from burn wounds in an Iranian University Hospital." Journal of research in pharmacy practice vol. 1,1 (2012): 30-3. doi: https://doi.org/10.4103/2279-042X.99675
Sabzghabaee AM, Abedi D, Fazeli H, Javadi A, Jalali M, Maracy MR, Soltani R, Karamyafti MJ. Antimicrobial resistance pattern of bacterial isolates from burn wounds in an Iranian University Hospital. J Res Pharm Pract. 2012 Jul;1(1):30-3. doi: 10.4103/2279-042X.99675. PMID: 24991585; PMCID: PMC4076853.
Copy Download .nbib Format: NLM
Share it on

J Res Pharm Pract. 2012 Jul;1(1):30-3. doi: 10.4103/2279-042X.99675.

Antimicrobial resistance pattern of bacterial isolates from burn wounds in an Iranian University Hospital.

Journal of research in pharmacy practice

Ali Mohammad Sabzghabaee, Daryoush Abedi, Hossein Fazeli, Abbasali Javadi, Mohammad Jalali, Mohammad Reza Maracy, Rasool Soltani, Mohammad Javad Karamyafti

Affiliations

  1. Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  2. Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  3. Department of Microbiology, Isfahan University of Medical Sciences, Isfahan, Iran.
  4. Department of Infectious Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
  5. Department of Food Science and Technology, Isfahan University of Medical Sciences, Isfahan, Iran.
  6. Department of Community Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

PMID: 24991585 PMCID: PMC4076853 DOI: 10.4103/2279-042X.99675

Abstract

OBJECTIVE: About 73% of death cases in the first 5 days after burning are due to infection complications. The aim of this study was to identify the causing agents of infections in burn patients and the sensitivity pattern of them to the commonly used antimicrobials in an Iranian Burn center University Hospital.

METHODS: In this cross-sectional study, patients who were admitted to one of the Iranian Burn center University hospitals in 2009 and had nosocomial infection due to burn wound, whom received antimicrobial agents for therapeutic reasons, with a hospitalization period of more than 48 hours were enrolled. Gram stain analyses were performed to help identifying growing colonies. Differential tests for identification of pathogenic bacteria species were performed following primary tests. E-test strips of each antimicrobial were placed on the culture medium plate in order to determine the minimum inhibitory concentration Studied antimicrobials for isolated Gram-negative bacteria were meropenem, piperacillin/tazobactam, ceftriaxone, cotrimoxazole, and for Staphylococcus aureus, vancomycin, piperacillin/tazobactam, cotrimoxazole, and cephalothin.

FINDINGS: Only 16% of Pseudomonas aeruginosa species were sensitive to meropenem, and 13% were sensitive to piperacillin/tazobactam. Ten out of 29 Klebsiella species (34%) were sensitive to meropenem and piperacillin/tazobactam. All isolated strains of Staphylococcus aureus were sensitive to vancomycine while they were all resistant to cotrimoxazole.

CONCLUSION: Pseudomona, Klebsiella and Staphylococcoci are the most common species causing burn infection in this medical center. Results showed the importance of limiting irrational use of wide-spectrum antimicrobials and recommends strict management of infections in burn injury centers.

Keywords: Antimicrobial drug resistance; burns; wound infection

References

  1. Drugs. 1990 Sep;40(3):364-73 - PubMed
  2. J Trauma. 1979 Sep;19(9):641-8 - PubMed
  3. Clin Microbiol Rev. 2006 Apr;19(2):403-34 - PubMed
  4. Indian J Med Res. 2007 Dec;126(6):541-4 - PubMed
  5. Burns. 2004 Jun;30(4):357-61 - PubMed
  6. World J Surg. 2005 Feb;29(2):131-48 - PubMed
  7. Indian J Pathol Microbiol. 1999 Jul;42(3):317-20 - PubMed
  8. J Burn Care Rehabil. 1987 Nov-Dec;8(6):509-12 - PubMed
  9. Arch Surg. 1986 Sep;121(9):1027-31 - PubMed
  10. Am J Infect Control. 2008 Jun;36(5):309-32 - PubMed
  11. Expert Opin Pharmacother. 2003 Mar;4(3):369-84 - PubMed
  12. Burns. 1995 Dec;21(8):575-9 - PubMed
  13. Am J Infect Control. 2004 Feb;32(1):23-6 - PubMed
  14. AACN Clin Issues. 2002 Aug;13(3):382-97 - PubMed
  15. Burns. 2000 Mar;26(2):178-80 - PubMed
  16. Curr Opin Infect Dis. 2004 Apr;17(2):91-6 - PubMed
  17. J Trauma. 1990 Dec;30(12 Suppl):S70-5 - PubMed
  18. Crit Care Clin. 1988 Apr;4(2):281-98 - PubMed
  19. Burns. 1998 Nov;24(7):637-41 - PubMed
  20. Burns. 2003 Mar;29(2):129-32 - PubMed
  21. J Hosp Infect. 2003 Jan;53(1):6-13 - PubMed
  22. Semin Nephrol. 1993 Jul;13(4):409-15 - PubMed

Publication Types